Spac

Israeli offensive cyber firm Paragon plans a New York Stock Exchange SPAC merger at a valuation of $1.5 to $2 billion, advised by Goldman Sachs and Jefferies.

A small US stock surged by the highest rate in the market, but behind the jump hides a technical mechanism rather than a business breakthrough. At the same time, Moderna jumped about 177% after a historic success in a personalized cancer vaccine trial. What separates speculation from revolution?